@article{095fe3c7ca494de5a155c5abc3cc3e7c,
title = "Anti CD20-based immunochemotherapy abolishes antibody response to Covid-19 mRNA vaccine in lymphoma patients vaccinated during active first line treatment",
abstract = "N/A",
keywords = "CD19+ B lymphocytes, COVID-19, Lymphoma, anti-CD20 immunotherapy, mRNA vaccine, CD19+ B lymphocytes, COVID-19, Lymphoma, anti-CD20 immunotherapy, mRNA vaccine",
author = "Silvia Bellesi and Michela Sali and Maiolo, \{Maria Elisa\} and \{Pereyra Boza\}, \{Maria Del Carmen\} and Eleonora Alma and Ivana Palucci and Federica Fatone and \{De Maio\}, Flavio and Marcello Viscovo and Francesco D'Alo' and \{De Stefano\}, Valerio and Stefan Hohaus and Maurizio Sanguinetti",
year = "2022",
doi = "10.1080/10428194.2022.2032042",
language = "English",
pages = "1--5--5",
journal = "LEUKEMIA \& LYMPHOMA",
issn = "1042-8194",
publisher = "Taylor \& Francis Limited:Rankine Road, Basingstoke RG24 8PR United Kingdom:011 44 1256 813035, EMAIL:
[email protected],
[email protected], INTERNET: http://www.tandf.co.uk, Fax: 011 44 1256 330245",
}
